Charles Briac L.
- Country
- France
- Department
- Oncologie
Research Overview
Data & Insights
Has run more than one trial at 35 of 105 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in advanced therapeutic approaches for various types of breast cancer, with particular focus on hormone receptor-positive (ER+/HER2-) metastatic breast cancer and triple-negative breast cancer (TNBC).
- Metastatic Disease Management
- Early-Stage Treatment Optimization
- Hormone Receptor-Positive Disease
Their research encompasses targeted therapeutic strategies and personalized treatment approaches.
Precision Medicine Applications
The investigator focuses on developing personalized treatment strategies through circulating tumor DNA detection and monitoring of ESR1 mutations in breast cancer patients.
- Biomarker-Driven Treatment
- Mutation Monitoring
- Treatment Response Assessment
Their work integrates molecular diagnostics with therapeutic decision-making.
Immunotherapy Research
The investigator studies immunotherapeutic approaches in breast cancer treatment, particularly focusing on pembrolizumab therapy in early-stage triple-negative breast cancer.
- Neoadjuvant Treatment Strategies
- Response-Guided Therapy
- Pathologic Complete Response Assessment
Their research evaluates optimal duration and timing of immunotherapy treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.